CLOV Nov 2024 1.500 call
| Previous Close | 0.1500 |
| Open | 0.1500 |
| Bid | 0.1000 |
| Ask | 0.1700 |
| Strike | 1.50 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.1500 - 0.1600 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 605 |
GlobeNewswireCMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year
The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars for 2025 payment yearFRANKLIN, Tenn., June 14, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare,
Simply Wall St.Clover Health Investments, Corp.'s (NASDAQ:CLOV) largest shareholders are retail investors with 58% ownership, insiders own 24%
Key Insights Clover Health Investments' significant retail investors ownership suggests that the key decisions are...
- GlobeNewswire
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers
FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, is excited to announce that its flagship clinical decision support tool, Clover Assistant, is now generally available for external payors and providers under the brand name Counterpart Assistant (“CA”). This strategic move with Counterpart
